Study of HS235 for Assessing the Pharmacokinetics, Safety, and Pharmacodynamics in Overweight/Obese Healthy Subjects

NCT06714825 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight and Obesity

Interventions

BIOLOGICAL: HS235
DRUG: Placebo

Sponsor

35Pharma Inc